This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Coagulation Analysers Market

Find Out How Rising Prevalence Of Blood Disorders Is Influencing The Sales of Coagulation Analyzers!

Coagulation Analysers Market by Product, End User & Region - Forecast for 2022 – 2032

Coagulation Analysers Market Outlook 2022-2032

[276 Pages Report] The global coagulation analysers market is expected to enjoy a valuation of US$ 1.1 Bn in 2022, and further expand at a CAGR of 6.8% between 2022 and 2032 to reach a valuation of ~US$ 2.1 Bn by 2032. Rising adoption across hospitals and clinical laboratories is a key factor driving demand for coagulation analyzers in the global market.

Based on product, the standalone analysers segment is estimated to lead the global coagulation analyzers market with a share of about 56.2% in 2022. This can be attributed to the rising end user preference for standalone analyzers over other product types.

Attribute

Key Statistics

Coagulation Analyzers Market Base Value (2021)

US$ 1.0 Bn

Estimated Market Value (2022)

US$ 1.1 Bn

Projected Market Value (2032)

US$ 2.1 Bn

Value-based CAGR (2022-2032)

6.8%

Market Share of Top 5 Countries

57.3%

Coagulation is the process by which blood converts from liquid state into a solid form leading to the formation of a clot indicating haemostasis. This is the stoppage of bleeding from a damaged vessel accompanied by repair. Coagulation involves adaptive immune responses, adhesion, and aggregation of blood components i.e. platelets, as well as fibrin deposition and maturation.

A coagulation analyzer is a machine that tests blood samples for the individual's blood clotting characteristics. One of the most significant qualities is blood clotting. When a person is injured, the clotting process starts to stop the blood flow by turning it into a gel. It can be exceedingly dangerous if there is an excessive or insufficient amount of clotting.

Coagulation analysers measure and evaluate the speed of clot formation or coagulation. They help to avoid the chances of heart attack, embolism, and thrombosis by detecting the presence of blood clots in blood vessels.

Rising usage of coagulation analysers for measuring coagulation factors and detecting/diagnosing diseases of bleeding and thrombus will therefore continue to boost the market during the forecast period.

The market value for coagulation analysers was approximately 2.8% of the overall ~US$ 37.0 Bn global point of care testing market in 2021.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Coagulation Analysers from 2012 to 2021 Vs Market Outlook for 2022 to 2032

The global sales of coagulation analysers are projected to grow at a healthy CAGR of 6.8% during the forecast period from 2022 to 2032. Rising prevalence of blood disorders and cardiovascular diseases and increasing usage of coagulation analyzers across various end user sectors are driving growth in the global market.

Coagulation analysers are becoming increasingly popular because of major improvements in technology and expanding healthcare industry requirements. Adoption rate of clinical chemistry analysers has expanded at a rapid pace during the last few decades and the trend is likely to continue during the forecast period. This will support the growth of coagulation analysers market.

Clinical chemistry is largely concerned with the examination of internal body fluids and provides accurate diagnostic information. Traditional laboratory tests have provided a solid foundation for standard medicine biochemistry. However, as technological advancements have grown, analysis techniques have advanced, and a series of tests can now be performed in automated laboratories utilising complex devices such as chemical analysers.

The demand for the coagulation analysers market will boost in the future as new government initiatives and development of quality of life programs are being introduced. For instance, the U.S. Department of Health and Human Services 2021, states that millions of Americans carry genes that can contribute to blood abnormalities such as sickle cell disease and haemophilia. As a result, programs like Healthy Individuals 2030 are being launched to improve the health and quality of life of people with blood diseases.

Sickle cell disease is a blood ailment that impacts more than 100,000 Americans. Interventions such as initiatives to boost hydroxyurea use can improve sickle cell disease patients' health outcomes, and blood transfusions can assist avoid and treat problems.Haemophilia is a chronic bleeding disorder primarily affecting men. Interventions that promote preventive therapy can help patients with haemophilia reduce joint damage and impairment.

In addition, increasing prevalence of blood disorders is expected to play a key role in augmenting the growth of coagulation analysers market during the forecast period. According to the Center for Disease Prevention and Control 2020, each year 1 in 5000 male births are affected with Haemophilia A. Similarly, the World Federation of Haemophilia (WHF) in their annual global survey 2021 stated that a total number of 347,026 patients were identified in 2020 suffering from haemophilic disorders.

Coagulation Analysers Market Download Report Brochure

What are the Key Trends Driving the Global Coagulation Analysers Market?

“Rising Government Initiatives and Advancements in Analyser Technology to Boost Growth of the Market Over the Projected Period”

The global coagulation analyzers market is expected to grow at a robust pace during the next ten years, owing to initiatives by governments in emerging countries that are engaging significantly in healthcare infrastructure development, which is expected to broaden access to healthcare services.

The frequency of coagulation screening tests ordered in recent years has skyrocketed. As a result, the effectiveness and efficacy of automated coagulation analysers have increased, allowing the development of high-throughput, accuracy rate, and exact analysers with limited human measurement error.

The first coagulation analysers were manually operated, with a hook used to identify a thrombus in the cuvette. This is currently superseded by the simultaneous detection of clotting components using colorimetric,clotting,and immunological principles.

Current technologies include flow cytometers, automated platelet function analysers,microarrays and polymerase chain reaction (PCR) have gained immense popularity. Combinations of all of these technologies reduce pre- and post-analytical handling, resulting in greater accuracy and productivity.

Thus, advancements in coagulation analysers will further create growth opportunities for manufacturers during the forecast period.

Sabyasachi Ghosh
Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

What are the Factors Restraining Growth of the Coagulation Analysers Market?

The high cost, regulatory challenges, lack of skilled workforce and low awareness levels regarding early detection of blood disorders in the field can hamper the growth of the coagulation analysers market during the forecast period.

Lack of awareness about prompt blood clot detection, as well as a scarcity of qualified coagulation analyzer operators, will also limit growth in the approaching years.

A huge section of the population in underdeveloped countries is still misinformed about the importance of frequent check-ups. Many people in developing countries lack access to adequate healthcare. During the projected period, such considerations may become obstacles to the growth of the coagulation analysers market.

Country-wise Insights

What Makes the U.S. a Dominant Coagulation Analysers Market?

“Rising Prevalence of Leukaemia Driving Market in the U.S.”

The U.S. will continue to dominate the North America coagulation analysers market with a total market share of about 90.1% in 2022. Growth in the U.S. coagulation analysers market is driven by rising incidence of blood disorders, availability of advanced medical technologies, and heavy presence of leading market players.

According to The Leukaemia & Lymphoma Society (LLS) 2021, one individual in the United States is diagnosed with leukaemia, lymphoma, or myeloma every three minutes. Furthermore, around 186,400 people were diagnosed with leukaemia, lymphoma, or myeloma in 2021 in the country and this number is likely to further surge during the coming years. This in turn will continue to push the demand for coagulation analysers in the U.S. market during the next ten years.

What Makes China a Highly Lucrative Coagulation Analysers Market?

Introduction of Advanced Coagulation Analysers Boosting Market in China”

As per FMI, China held approximately 4.7% share in the global coagulation analysers market in 2021 and it is projected to grow at the highest CAGR of 7.1% during the forecast period.

Rapid expansion of healthcare industry, increasing incidence of blood disorders, and growing adoption of advanced coagulation analysers across hospitals and clinical laboratories are driving the market in China.

Similarly, advancements in analyser technology and continuous introduction of new products by leading market players are expected to boost China’s coagulation analysers market during the assessment period.

Leading players based in China are continuously focused on developing products with greater efficiency. For instance, recently The Roche Cobast 711, a new automatic blood coagulation analyzer was introduced in China. The analyzer has a sample capacity of 225 and can do up to 390 tests per hour, as well as automatic verification of sample tube pressure and quality to detect the presence of interfering chemicals such as cell-free haemoglobin, bilirubin, and lipids.

The new devices can significantly improve detection speed and enable end users to improve their productivity. Availability of such products will further expand the coagulation analysers market size in China during the assessment period.

What is the Demand Outlook for Germany Coagulation Analysers Market?

“Flourishing Medical Tourism Boosting Sales in Germany”

The coagulation analysers market in Germany is set to exhibit a CAGR of nearly 4.4% during the forecast period. Growth in the market is driven by rising cases of thalassemia, increasing adoption of advanced medical technologies, and increasing diagnostic screening rates in the country.

Similarly, increasing medical tourism and rapid expansion of clinical laboratories are expected to generate demand for coagulation analysers across the country during the next decade.

MarketNage
Become a MarketNgage Insider

A unified Market Research Subscription Platform, built for today's disparate research needs.

Category-wise Insights

Which is the Most Popular Product in Coagulation Analyzers Market?

“Standalone Coagulation Analyzers Will Remain Highly Sought After Products”

As per FMI, the standalone coagulation analysers segment is expected to grow at a CAGR of 6.3% during the forecast period, accounting for the largest market share of about 56.2% by the end of 2022. This can be attributed to the rising end user preference for these efficient and cost effective products.

Similary, various benefits of standalone coagulation analyzers including easy accessibility at bedside in the hospitals and increased adoption of analysers in emergency cases in the operating rooms will further accelerate the growth of this segment during the forecast period.

Which is the Leading End User of Coagulation Analysers Globally?

“Most of the Coagulation Analyzer Sales to Remain Concentrated in Clinical Laboratories”

Based on end users, clinical laboratories segment will hold the highest market share value of 59.9% in 2022 and further expand at a robust pace during the forecast period. Rising inpatient admissions, increasing surgical procedures, and the fact of routine examinations carried out prior to any procedures are propelling growth of this segment.

Competitive Landscape

With several competitors in the coagulation analyser’s production sphere, the overall market is fragmented. To meet consumer demand and expand their customer base, leading companies are adopting strategies such as mergers and acquisitions, partnerships and collaborations, and new product launches.

Instances of key developmental strategies by the industry players in the coagulation analysers market are given below:

  • In June 2021, Trivitron Healthcare announced the release of two new product innovations for HbA1c and Hb variant detection. The NANO H5 and NANO H110 are high performance liquid chromatography analysers for HbA1c detection in less than 3 minutes. These HbA1c analysers based on HPLC will be utilised to monitor diabetes, thalassemia, and haemoglobin variations.
  • In February 2021, Siemens Healthineers and Sysmex Corporation announced the renewal of their long-standing global distributorship,supply,service agreement, and sales,for a comprehensive portfolio of blood clotting products including a multi-year extension. The businesses' agreement also includes Siemens Healthineers' future distribution of Sysmex's CN-Series automated blood coagulation analysers, the CN-3000 and CN-6000, providing the next generation of completely automated solutions for mid- and high-volume coagulation testing to laboratories.
  • In October 2021, Trivitron Healthcare in collaboration with Diagon launched a new line of coagulation analyzer products for the Indian market.

Report Scope as per Coagulation Analysers Industry Analysis

Attribute

Details

Estimated Market Size (2022)

US$ 1.1 Bn

Projected Market Size (2032)

US$ 2.1 Bn

Anticipated Growth Rate (2022-2032)

6.8%

Forecast Period

2012-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Mn for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania, and Middle East & Africa

Key Countries Covered

U.S., Canada, Brazil, Mexico, Argentina, U.K., Germany, Italy, Russia, Spain, France, BENELUX, Nordic Countries, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Turkey, GCC, South Africa and North Africa

Key Market Segments Covered

Product, End User, and Region

Key Companies Profiled

  • Meril Life Sciences
  • Robimes India Pvt. Ltd.
  • Bpc Biosed Srl
  • Hycel, Eurolyser
  • Helena Laboratories
  • Diagnostica Stago SAS
  • Beijing Succeeder Technology Inc.
  • A&T Corporation
  • Genrui Biotech Inc.
  • Bio Group Medical System
  • Maccura Biotechnology Co. Ltd
  • Roche Diagnostics
  • Abbott Laboratories
  • Danaher
  • Siemens Healthineers Group
  • Sysmex Group
  • Thermo Fisher Scientific
  • Horiba
  • Nihon Kohden
  • ERBA Diagnostics, Inc.
  • Sclavo Diagnostics International S.r.l
  • Haematonics
  • Biosystems S.A.
  • ACON.

Key Market Segments Covered in Coagulation Analysers Industry Research

By Product:

  • Standalone Analyzers
  • Table Top Analyzers
  • Portable Analyzers

By End User:

  • Hospitals
  • Clinical Laboratories
  • Others

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Frequently Asked Questions

The global coagulation analysers market was valued at US$ 1.0 Bn in 2021 and is set to touch a valuation of US$ 1.1 Bn by 2022.

The coagulation analysers market is expected to reach US$ 2.1 Bn by the end of 2032, with sales revenue expected to grow at 6.2% CAGR throughout the forecast period.

Advances in hemostasis-coagulation analyzer technology, rising prevalence of lifestyle-related diseases, and increasing initiatives by government bodies are some of the key trends shaping growth in this market.

The U.S., China, Germany, Japan, and the U.K. are driving demand for coagulation analysers.

The U.S. is expected to account for about 90.1% of the North American coagulation analysers market in 2022.

Demand for coagulation analysers in Europe is expected to rise at 6.9% CAGR over the next ten years.

The coagulation analysers market in Latin America is expected to grow at 6.6% CAGR during the forecast period.

The overall coagulation analyzers market in MEA is likely to expand at a CAGR of 6.0% over the next ten years

The U.S., China, and Japan are the key producers of coagulation analysers.

Abbott Laboratories, Danaher, Siemens Healthineers Group, Sysmex Group, Thermo Fisher Scientific, Horiba, Nihon Kohden, Roche Diagnostics, Maccura Biotechnology Co. Ltd, Bio Group Medical System, Genrui Biotech Inc., A&T Corporation, Beijing Succeeder Technology Inc., Diagnostica Stago SAS, Helena Laboratories, Hycel, Eurolyser, Bpc Biosed Srl, Robimes India Pvt. Ltd., Meril Life Sciences, ERBA Diagnostics, Inc., Sclavo Diagnostics International S.r.l, Haematonics, Biosystems S.A., and ACON are

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Technology Roadmap

    1.5. Analysis and Recommendations

2. Market Overview

    2.1. Market Coverage / Taxonomy

    2.2. Market Definition / Scope / Limitations

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Disease Epidemiology

    4.2. Regulatory Scenario

    4.3. Reimbursement Landscape

    4.4. PESTEL analysis

    4.5. Porter’s analysis

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP Growth Outlook

        5.1.2. Global Healthcare GDP Growth Overview

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Rising prevalence of blood disorders.

        5.2.2. Increasing Awareness and Adoption of in Healthcare Settings.

        5.2.3. New Product Launches

        5.2.4. Advancing medical technology and developments of Coagulation Analysers.

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

6. COVID-19 Crisis – Crisis Analysis

    6.1. COVID-19 and Impact Analysis

        6.1.1. By Product

        6.1.2. By End User

        6.1.3. By Region

    6.2. 2021 Market Scenario

7. Global Market Volume (Units) Analysis 2012-2021 and Forecast, 2022–2032

    7.1. Historical Market Volume (Units) Analysis, 2012-2021

    7.2. Current and Future Market Volume (Units) Projections, 2022–2032

        7.2.1. Y-o-Y Growth Trend Analysis

8. Global Market - Pricing Analysis

    8.1. Regional Pricing Analysis By Product

    8.2. Pricing Break-up

        8.2.1. Manufacturer Level Pricing

        8.2.2. Distributor Level Pricing

    8.3. Global Average Pricing Analysis Benchmark

    8.4. Pricing Assumptions

9. Global Market Demand (in Value or Size in US$ Mn) Analysis 2012-2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Mn) Analysis, 2012-2021

    9.2. Current and Future Market Value (US$ Mn) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Market Analysis 2012-2021 and Forecast 2022–2032, by Product

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product , 2012-2021

    10.3. Current and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Product , 2022–2032

        10.3.1. Standalone Analysers

        10.3.2. Table Top Analysers

        10.3.3. Portable Analysers

    10.4. Market Attractiveness Analysis By Product

11. Global Market Analysis 2012-2021 and Forecast 2022–2032, by End User

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Mn) Analysis, By End User, 2012-2021

    11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2022–2032

        11.3.1. Hospitals

        11.3.2. Clinical Laboratories

        11.3.3. Others

    11.4. Market Attractiveness Analysis By End User

12. Global Market Analysis 2012-2021 and Forecast 2022–2032, by Region

    12.1. Introduction

    12.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2012-2021

    12.3. Current Market and Future Market Size (US$ Mn) and Volume (Units) Analysis and Forecast By Region, 2022–2032

        12.3.1. North America

        12.3.2. Latin America

        12.3.3. Europe

        12.3.4. East Asia

        12.3.5. South Asia

        12.3.6. Oceania

        12.3.7. Middle East and Africa (MEA)

    12.4. Market Attractiveness Analysis By Region

13. North America Market Analysis 2012-2021 and Forecast 2022–2032

    13.1. Introduction

    13.2. Pricing Analysis

    13.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    13.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        13.4.1. By Country

            13.4.1.1. U.S.

            13.4.1.2. Canada

        13.4.2. By Product

        13.4.3. By End User

    13.5. Market Attractiveness Analysis

        13.5.1. By Country

        13.5.2. By Product

        13.5.3. By End User

    13.6. Market Trends

    13.7. Key Market Participants - Intensity Mapping

    13.8. Drivers and Restraints - Impact Analysis

    13.9. Country Level Analysis & Forecast

        13.9.1. U.S. Market Analysis

            13.9.1.1. .Introduction

            13.9.1.2. Market Analysis and Forecast by Market Taxonomy

                13.9.1.2.1. By Product

                13.9.1.2.2. By End User

        13.9.2. Canada Market Analysis

            13.9.2.1. Introduction

            13.9.2.2. Market Analysis and Forecast by Market Taxonomy

                13.9.2.2.1. By Product

                13.9.2.2.2. By End User

14. Latin America Market Analysis 2012-2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    14.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. Mexico

            14.4.1.2. Brazil

            14.4.1.3. Argentina

            14.4.1.4. Rest of Latin America

        14.4.2. By Product

        14.4.3. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Product

        14.5.3. By End User

    14.6. Market Trends

    14.7. Key Market Participants - Intensity Mapping

    14.8. Drivers and Restraints - Impact Analysis

    14.9. Country Level Analysis & Forecast

        14.9.1. Mexico Market Analysis

            14.9.1.1. Introduction

            14.9.1.2. Market Analysis and Forecast by Market Taxonomy

                14.9.1.2.1. By Product

                14.9.1.2.2. By End User

        14.9.2. Brazil Market Analysis

            14.9.2.1. Introduction

            14.9.2.2. Market Analysis and Forecast by Market Taxonomy

                14.9.2.2.1. By Product

                14.9.2.2.2. By End User

        14.9.3. Argentina Market Analysis

            14.9.3.1. Introduction

            14.9.3.2. Market Analysis and Forecast by Market Taxonomy

                14.9.3.2.1. By Product

                14.9.3.2.2. By End User

15. Europe Market Analysis 2012-2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    15.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        15.4.1. By Country

            15.4.1.1. Germany

            15.4.1.2. Italy

            15.4.1.3. France

            15.4.1.4. U.K.

            15.4.1.5. Spain

            15.4.1.6. BENELUX

            15.4.1.7. Russia

            15.4.1.8. Rest of Europe

        15.4.2. By Product

        15.4.3. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Product

        15.5.3. By End User

    15.6. Market Trends

    15.7. Key Market Participants - Intensity Mapping

    15.8. Drivers and Restraints - Impact Analysis

    15.9. Country Level Analysis & Forecast

        15.9.1. Germany Market Analysis

            15.9.1.1. Introduction

            15.9.1.2. Market Analysis and Forecast by Market Taxonomy

                15.9.1.2.1. By Product

                15.9.1.2.2. By End User

        15.9.2. Italy Market Analysis

            15.9.2.1. Introduction

            15.9.2.2. Market Analysis and Forecast by Market Taxonomy

                15.9.2.2.1. By Product

                15.9.2.2.2. By End User

        15.9.3. France Market Analysis

            15.9.3.1. Introduction

            15.9.3.2. Market Analysis and Forecast by Market Taxonomy

                15.9.3.2.1. By Product

                15.9.3.2.2. By End User

        15.9.4. U.K. Market Analysis

            15.9.4.1. Introduction

            15.9.4.2. Market Analysis and Forecast by Market Taxonomy

                15.9.4.2.1. By Product

                15.9.4.2.2. By End User

        15.9.5. Spain Market Analysis

            15.9.5.1. Introduction

            15.9.5.2. Market Analysis and Forecast by Market Taxonomy

                15.9.5.2.1. By Product

                15.9.5.2.2. By End User

        15.9.6. BENELUX Market Analysis

            15.9.6.1. Introduction

            15.9.6.2. Market Analysis and Forecast by Market Taxonomy

                15.9.6.2.1. By Product

                15.9.6.2.2. By End User

        15.9.7. Russia Market Analysis

            15.9.7.1. Introduction

            15.9.7.2. Market Analysis and Forecast by Market Taxonomy

                15.9.7.2.1. By Product

                15.9.7.2.2. By End User

16. South Asia Market Analysis 2012-2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    16.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        16.4.1. By Country

            16.4.1.1. India

            16.4.1.2. Indonesia

            16.4.1.3. Malaysia

            16.4.1.4. Thailand

            16.4.1.5. Rest of South Asia

        16.4.2. By Product

        16.4.3. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Product

        16.5.3. By End User

    16.6. Market Trends

    16.7. Key Market Participants - Intensity Mapping

    16.8. Drivers and Restraints - Impact Analysis

    16.9. Country Level Analysis & Forecast

        16.9.1. India Market Analysis

            16.9.1.1. Introduction

            16.9.1.2. Market Analysis and Forecast by Market Taxonomy

                16.9.1.2.1. By Product

                16.9.1.2.2. By End User

        16.9.2. Indonesia Market Analysis

            16.9.2.1. Introduction

            16.9.2.2. Market Analysis and Forecast by Market Taxonomy

                16.9.2.2.1. By Product

                16.9.2.2.2. By End User

        16.9.3. Malaysia Market Analysis

            16.9.3.1. Introduction

            16.9.3.2. Market Analysis and Forecast by Market Taxonomy

                16.9.3.2.1. By Product

                16.9.3.2.2. By End User

        16.9.4. Thailand Market Analysis

            16.9.4.1. Introduction

            16.9.4.2. Market Analysis and Forecast by Market Taxonomy

                16.9.4.2.1. By Product

                16.9.4.2.2. By End User

17. East Asia Market Analysis 2012-2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    17.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. China

            17.4.1.2. Japan

            17.4.1.3. South Korea

        17.4.2. By Product

        17.4.3. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Product

        17.5.3. By End User

    17.6. Market Trends

    17.7. Key Market Participants - Intensity Mapping

    17.8. Drivers and Restraints - Impact Analysis

    17.9. Country Level Analysis & Forecast

        17.9.1. China Market Analysis

            17.9.1.1. Introduction

            17.9.1.2. Market Analysis and Forecast by Market Taxonomy

                17.9.1.2.1. By Product

                17.9.1.2.2. By End User

        17.9.2. Japan Market Analysis

            17.9.2.1. Introduction

            17.9.2.2. Market Analysis and Forecast by Market Taxonomy

                17.9.2.2.1. By Product

                17.9.2.2.2. By End User

        17.9.3. South Korea Market Analysis

            17.9.3.1. Introduction

            17.9.3.2. Market Analysis and Forecast by Market Taxonomy

                17.9.3.2.1. By Product

                17.9.3.2.2. By End User

18. Oceania Market 2012-2021 and Forecast 2022-2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    18.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        18.4.1. By Country

            18.4.1.1. Australia

            18.4.1.2. New Zealand

        18.4.2. By Product

        18.4.3. By End User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Product

        18.5.3. By End User

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

    18.8. Country Level Analysis & Forecast

        18.8.1. Australia Market Analysis

            18.8.1.1. Introduction

            18.8.1.2. Market Analysis and Forecast by Market Taxonomy

                18.8.1.2.1. By Product

                18.8.1.2.2. By End User

        18.8.2. New Zealand Market Analysis

            18.8.2.1. Introduction

            18.8.2.2. Market Analysis and Forecast by Market Taxonomy

                18.8.2.2.1. By Product

                18.8.2.2.2. By End User

19. Middle East and Africa (MEA) Market Analysis 2012-2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Mn) and Volume (Units) Trend Analysis By Market Taxonomy, 2012-2021

    19.4. Current and Future Market Size (US$ Mn) and Volume (Units) Forecast By Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. GCC Countries

            19.4.1.2. Turkey

            19.4.1.3. South Africa

            19.4.1.4. North Africa

            19.4.1.5. Rest of Middle East and Africa

        19.4.2. By Product

        19.4.3. By End User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Product

        19.5.3. By End User

    19.6. Market Trends

    19.7. Key Market Participants - Intensity Mapping

    19.8. Drivers and Restraints - Impact Analysis

    19.9. Country Level Analysis & Forecast

        19.9.1. GCC Countries Market Analysis

            19.9.1.1. Introduction

            19.9.1.2. Market Analysis and Forecast by Market Taxonomy

                19.9.1.2.1. By Product

                19.9.1.2.2. By End User

        19.9.2. Turkey Market Analysis

            19.9.2.1. Introduction

            19.9.2.2. Market Analysis and Forecast by Market Taxonomy

                19.9.2.2.1. By Product

                19.9.2.2.2. By End User

        19.9.3. South Africa Market Analysis

            19.9.3.1. Introduction

            19.9.3.2. Market Analysis and Forecast by Market Taxonomy

                19.9.3.2.1. By Product

                19.9.3.2.2. By End User

        19.9.4. North Africa Market Analysis

            19.9.4.1. Introduction

            19.9.4.2. Market Analysis and Forecast by Market Taxonomy

                19.9.4.2.1. By Product

                19.9.4.2.2. By End User

20. Market Structure Analysis

    20.1. Market Analysis by Tier of Companies

    20.2. Market Share Analysis of Top Players

    20.3. Market Presence Analysis

21. Competition Analysis

    21.1. Competition Dashboard

    21.2. Competition Benchmarking

    21.3. Competition Deep Dive

        21.3.1. Thermo Fisher Scientific,

            21.3.1.1. Overview

            21.3.1.2. Product Portfolio

            21.3.1.3. Sales Footprint

            21.3.1.4. SWOT Analysis

            21.3.1.5. Key Financials

            21.3.1.6. Strategy Overview

        21.3.2. Meril Life Sciences,

            21.3.2.1. Overview

            21.3.2.2. Product Portfolio

            21.3.2.3. Sales Footprint

            21.3.2.4. SWOT Analysis

            21.3.2.5. Key Financials

            21.3.2.6. Strategy Overview

        21.3.3. Robimes India Pvt. Ltd.,

            21.3.3.1. Overview

            21.3.3.2. Product Portfolio

            21.3.3.3. Sales Footprint

            21.3.3.4. SWOT Analysis

            21.3.3.5. Key Financials

            21.3.3.6. Strategy Overview

        21.3.4. Bpc Biosed Srl,

            21.3.4.1. Overview

            21.3.4.2. Product Portfolio

            21.3.4.3. Sales Footprint

            21.3.4.4. SWOT Analysis

            21.3.4.5. Key Financials

            21.3.4.6. Strategy Overview

        21.3.5. Hycel, Eurolyser,

            21.3.5.1. Overview

            21.3.5.2. Product Portfolio

            21.3.5.3. Sales Footprint

            21.3.5.4. SWOT Analysis

            21.3.5.5. Key Financials

            21.3.5.6. Strategy Overview

        21.3.6.  Helena Laboratories,

            21.3.6.1. Overview

            21.3.6.2. Product Portfolio

            21.3.6.3. Sales Footprint

            21.3.6.4. SWOT Analysis

            21.3.6.5. Key Financials

            21.3.6.6. Strategy Overview

        21.3.7. Diagnostica Stago SAS,

            21.3.7.1. Overview

            21.3.7.2. Product Portfolio

            21.3.7.3. Sales Footprint

            21.3.7.4. SWOT Analysis

            21.3.7.5. Key Financials

            21.3.7.6. Strategy Overview

        21.3.8. Beijing Succeeder Technology Inc.,

            21.3.8.1. Overview

            21.3.8.2. Product Portfolio

            21.3.8.3. Sales Footprint

            21.3.8.4. SWOT Analysis

            21.3.8.5. Key Financials

            21.3.8.6. Strategy Overview

        21.3.9. A&T Corporation,

            21.3.9.1. Overview

            21.3.9.2. Product Portfolio

            21.3.9.3. Sales Footprint

            21.3.9.4. SWOT Analysis

            21.3.9.5. Key Financials

            21.3.9.6. Strategy Overview

        21.3.10. Genrui Biotech Inc.,

            21.3.10.1. Overview

            21.3.10.2. Product Portfolio

            21.3.10.3. Sales Footprint

            21.3.10.4. SWOT Analysis

            21.3.10.5. Key Financials

            21.3.10.6. Strategy Overview

        21.3.11. Bio Group Medical System,

            21.3.11.1. Overview

            21.3.11.2. Product Portfolio

            21.3.11.3. Sales Footprint

            21.3.11.4. SWOT Analysis

            21.3.11.5. Key Financials

            21.3.11.6. Strategy Overview

        21.3.12. Maccura Biotechnology Co. Ltd,

            21.3.12.1. Overview

            21.3.12.2. Product Portfolio

            21.3.12.3. Sales Footprint

            21.3.12.4. SWOT Analysis

            21.3.12.5. Key Financials

            21.3.12.6. Strategy Overview

        21.3.13. Roche Diagnostics,

            21.3.13.1. Overview

            21.3.13.2. Product Portfolio

            21.3.13.3. Sales Footprint

            21.3.13.4. SWOT Analysis

            21.3.13.5. Key Financials

            21.3.13.6. Strategy Overview

        21.3.14. Abbott Laboratories,

            21.3.14.1. Overview

            21.3.14.2. Product Portfolio

            21.3.14.3. Sales Footprint

            21.3.14.4. SWOT Analysis

            21.3.14.5. Key Financials

            21.3.14.6. Strategy Overview

        21.3.15. Danaher,

            21.3.15.1. Overview

            21.3.15.2. Product Portfolio

            21.3.15.3. Sales Footprint

            21.3.15.4. SWOT Analysis

            21.3.15.5. Key Financials

            21.3.15.6. Strategy Overview

        21.3.16. Siemens Healthineers Group,

            21.3.16.1. Overview

            21.3.16.2. Product Portfolio

            21.3.16.3. Sales Footprint

            21.3.16.4. SWOT Analysis

            21.3.16.5. Key Financials

            21.3.16.6. Strategy Overview

        21.3.17. Sysmex Group

            21.3.17.1. Overview

            21.3.17.2. Product Portfolio

            21.3.17.3. Sales Footprint

            21.3.17.4. SWOT Analysis

            21.3.17.5. Key Financials

            21.3.17.6. Strategy Overview

        21.3.18. Horiba,

            21.3.18.1. Overview

            21.3.18.2. Product Portfolio

            21.3.18.3. Sales Footprint

            21.3.18.4. SWOT Analysis

            21.3.18.5. Key Financials

            21.3.18.6. Strategy Overview

        21.3.19. Nihon Kohden,

            21.3.19.1. Overview

            21.3.19.2. Product Portfolio

            21.3.19.3. Sales Footprint

            21.3.19.4. SWOT Analysis

            21.3.19.5. Key Financials

            21.3.19.6. Strategy Overview

        21.3.20. ERBA Diagnostics, Inc.,

            21.3.20.1. Overview

            21.3.20.2. Product Portfolio

            21.3.20.3. Sales Footprint

            21.3.20.4. SWOT Analysis

            21.3.20.5. Key Financials

            21.3.20.6. Strategy Overview

        21.3.21. Sclavo Diagnostics International S.r.l,

            21.3.21.1. Overview

            21.3.21.2. Product Portfolio

            21.3.21.3. Sales Footprint

            21.3.21.4. SWOT Analysis

            21.3.21.5. Key Financials

            21.3.21.6. Strategy Overview

        21.3.22. Haematonics,

            21.3.22.1. Overview

            21.3.22.2. Product Portfolio

            21.3.22.3. Sales Footprint

            21.3.22.4. SWOT Analysis

            21.3.22.5. Key Financials

            21.3.22.6. Strategy Overview

        21.3.23. Biosystems S.A.,

            21.3.23.1. Overview

            21.3.23.2. Product Portfolio

            21.3.23.3. Sales Footprint

            21.3.23.4. SWOT Analysis

            21.3.23.5. Key Financials

            21.3.23.6. Strategy Overview

        21.3.24. ACON.

            21.3.24.1. Overview

            21.3.24.2. Product Portfolio

            21.3.24.3. Sales Footprint

            21.3.24.4. SWOT Analysis

            21.3.24.5. Key Financials

            21.3.24.6. Strategy Overview

22. Assumptions and Acronyms Used

23. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 02: Global Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 03: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 04: Global Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Region

Table 05: North America Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 06: North America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 07: North America Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 08: North America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 09: Latin America Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 10: Latin America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 11: Latin America Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 12: Latin America Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 13: Europe Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 14: Europe Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 15: Europe Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 16: Europe Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 17: South Asia Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 18: South Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 19: South Asia Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 20: South Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 21: East Asia Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 22: East Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 23: East Asia Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 24: East Asia Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 25: Oceania Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 26: Oceania Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 27: Oceania Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 28: Oceania Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Table 29: MEA Market Value (US$ Mn) Analysis 2012-2021 and Forecast 2022–2032, by Country

Table 30: MEA Market Value (US$ Mn) Analysis and Forecast 2012–2032, by Product

Table 31: MEA Market Volume (Units) Analysis and Forecast 2012–2032, by Product

Table 32: MEA Market Value (US$ Mn) Analysis and Forecast 2012–2032, by End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Market Volume (Units), 2012-2021

Figure 02: Global Market Volume (Units) & Y-o-Y Growth (%) Analysis, 2022–2032

Figure 03: Market, Pricing Analysis per unit (US$), in 2022

Figure 04: Market, Pricing Forecast per unit (US$), in 2032

Figure 05: Global Market Value (US$ Mn) Analysis, 2012-2021

Figure 06: Global Market Forecast & Y-o-Y Growth, 2022–2032

Figure 07: Global Market Absolute $ Opportunity (US$ Mn) Analysis, 2021–2032

Figure 08: Global Market Value Share (%) Analysis 2022 and 2032, by Product

Figure 09: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Product

Figure 10: Global Market Attractiveness Analysis 2022–2032, by Product

Figure 11: Global Market Value Share (%) Analysis 2022 and 2032, by End User

Figure 12: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by End User

Figure 13: Global Market Attractiveness Analysis 2022–2032, by End User

Figure 14: Global Market Value Share (%) Analysis 2022 and 2032, by Region

Figure 15: Global Market Y-o-Y Growth (%) Analysis 2021-2032, by Region

Figure 16: Global Market Attractiveness Analysis 2022–2032, by Region

Figure 17: North America Market Value (US$ Mn) Analysis, 2012-2021

Figure 18: North America Market Value (US$ Mn) Forecast, 2022-2032

Figure 19: North America Market Value Share, by Product (2022 E)

Figure 20: North America Market Value Share, by End User (2022 E)

Figure 21: North America Market Value Share, by Country (2022 E)

Figure 22: North America Market Attractiveness Analysis by Product, 2022–2032

Figure 23: North America Market Attractiveness Analysis by End User, 2022–2032

Figure 24: North America Market Attractiveness Analysis by Country, 2022–2032

Figure 25: U.S. Market Value Proportion Analysis, 2021

Figure 26: Global Vs. U.S. Growth Comparison, 2021 - 2032

Figure 27: U.S. Market Share Analysis (%) by Product, 2021 & 2032

Figure 28: U.S. Market Share Analysis (%) by End User, 2021 & 2032

Figure 29: Canada Market Value Proportion Analysis, 2021

Figure 30: Global Vs. Canada. Growth Comparison, 2021 - 2032

Figure 31: Canada Market Share Analysis (%) by Product, 2021 & 2032

Figure 32: Canada Market Share Analysis (%) by End User, 2021 & 2032

Figure 33: Latin America Market Value (US$ Mn) Analysis, 2012-2021

Figure 34: Latin America Market Value (US$ Mn) Forecast, 2022-2032

Figure 35: Latin America Market Value Share, by Product (2022 E)

Figure 36: Latin America Market Value Share, by End User (2022 E)

Figure 37: Latin America Market Value Share, by Country (2022 E)

Figure 38: Latin America Market Attractiveness Analysis by Product, 2022–2032

Figure 39: Latin America Market Attractiveness Analysis by End User, 2022–2032

Figure 40: Latin America Market Attractiveness Analysis by Country, 2022–2032

Figure 41: Mexico Market Value Proportion Analysis, 2021

Figure 42: Global Vs Mexico Growth Comparison, 2021 - 2032

Figure 43: Mexico Market Share Analysis (%) by Product, 2021 & 2032

Figure 44: Mexico Market Share Analysis (%) by End User, 2021 & 2032

Figure 45: Brazil Market Value Proportion Analysis, 2021

Figure 46: Global Vs. Brazil. Growth Comparison, 2021 - 2032

Figure 47: Brazil Market Share Analysis (%) by Product, 2021 & 2032

Figure 48: Brazil Market Share Analysis (%) by End User, 2021 & 2032

Figure 49: Argentina Market Value Proportion Analysis, 2021

Figure 50: Global Vs Argentina Growth Comparison, 2021 - 2032

Figure 51: Argentina Market Share Analysis (%) by Product, 2021 & 2032

Figure 52: Argentina Market Share Analysis (%) by End User, 2021 & 2032

Figure 53: Europe Market Value (US$ Mn) Analysis, 2012-2021

Figure 54: Europe Market Value (US$ Mn) Forecast, 2022-2032

Figure 55: Europe Market Value Share, by Product (2022 E)

Figure 56: Europe Market Value Share, by End User (2022 E)

Figure 57: Europe Market Value Share, by Country (2022 E)

Figure 58: Europe Market Attractiveness Analysis by Product, 2022–2032

Figure 59: Europe Market Attractiveness Analysis by End User, 2022–2032

Figure 60: Europe Market Attractiveness Analysis by Country, 2022–2032

Figure 61: UK Market Value Proportion Analysis, 2021

Figure 62: Global Vs. UK Growth Comparison, 2021 - 2032

Figure 63: UK Market Share Analysis (%) by Product, 2021 & 2032

Figure 64: UK Market Share Analysis (%) by End User, 2021 & 2032

Figure 65: Germany Market Value Proportion Analysis, 2021

Figure 66: Global Vs. Germany Growth Comparison, 2021 - 2032

Figure 67: Germany Market Share Analysis (%) by Product, 2021 & 2032

Figure 68: Germany Market Share Analysis (%) by End User, 2021 & 2032

Figure 69: Italy Market Value Proportion Analysis, 2021

Figure 70: Global Vs. Italy Growth Comparison, 2021 - 2032

Figure 71: Italy Market Share Analysis (%) by Product, 2021 & 2032

Figure 72: Italy Market Share Analysis (%) by End User, 2021 & 2032

Figure 73: France Market Value Proportion Analysis, 2021

Figure 74: Global Vs France Growth Comparison, 2021 - 2032

Figure 75: France Market Share Analysis (%) by Product, 2021 & 2032

Figure 76: France Market Share Analysis (%) by End User, 2021 & 2032

Figure 77: Spain Market Value Proportion Analysis, 2021

Figure 78: Global Vs Spain Growth Comparison, 2021 - 2032

Figure 79: Spain Market Share Analysis (%) by Product, 2021 & 2032

Figure 80: Spain Market Share Analysis (%) by End User, 2021 & 2032

Figure 81: Russia Market Value Proportion Analysis, 2021

Figure 82: Global Vs Russia Growth Comparison, 2021 - 2032

Figure 83: Russia Market Share Analysis (%) by Product, 2021 & 2032

Figure 84: Russia Market Share Analysis (%) by End User, 2021 & 2032

Figure 85: BENELUX Market Value Proportion Analysis, 2021

Figure 86: Global Vs BENELUX Growth Comparison, 2021 - 2032

Figure 87: BENELUX Market Share Analysis (%) by Product, 2021 & 2032

Figure 88: BENELUX Market Share Analysis (%) by End User, 2021 & 2032

Figure 89: East Asia Market Value (US$ Mn) Analysis, 2012-2021

Figure 90: East Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 91: East Asia Market Value Share, by Product (2022 E)

Figure 92: East Asia Market Value Share, by End User (2022 E)

Figure 93: East Asia Market Value Share, by Country (2022 E)

Figure 94: East Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 95: East Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 96: East Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 97: China Market Value Proportion Analysis, 2021

Figure 98: Global Vs. China Growth Comparison, 2021 - 2032

Figure 99: China Market Share Analysis (%) by Product, 2021 & 2032

Figure 100: China Market Share Analysis (%) by End User, 2021 & 2032

Figure 101: Japan Market Value Proportion Analysis, 2021

Figure 102: Global Vs. Japan Growth Comparison, 2021 - 2032

Figure 103: Japan Market Share Analysis (%) by Product, 2021 & 2032

Figure 104: Japan Market Share Analysis (%) by End User, 2021 & 2032

Figure 105: South Korea Market Value Proportion Analysis, 2021

Figure 106: Global Vs South Korea Growth Comparison, 2021 - 2032

Figure 107: South Korea Market Share Analysis (%) by Product, 2021 & 2032

Figure 108: South Korea Market Share Analysis (%) by End User, 2021 & 2032

Figure 109: South Asia Market Value (US$ Mn) Analysis, 2012-2021

Figure 110: South Asia Market Value (US$ Mn) Forecast, 2022-2032

Figure 111: South Asia Market Value Share, by Product (2022 E)

Figure 112: South Asia Market Value Share, by End User (2022 E)

Figure 113: South Asia Market Value Share, by Country (2022 E)

Figure 114: South Asia Market Attractiveness Analysis by Product, 2022–2032

Figure 115: South Asia Market Attractiveness Analysis by End User, 2022–2032

Figure 116: South Asia Market Attractiveness Analysis by Country, 2022–2032

Figure 117: India Market Value Proportion Analysis, 2021

Figure 118: Global Vs. India Growth Comparison, 2021 - 2032

Figure 119: India Market Share Analysis (%) by Product, 2021 & 2032

Figure 120: India Market Share Analysis (%) by End User, 2021 & 2032

Figure 121: Indonesia Market Value Proportion Analysis, 2021

Figure 122: Global Vs. Indonesia Growth Comparison, 2021 - 2032

Figure 123: Indonesia Market Share Analysis (%) by Product, 2021 & 2032

Figure 124: Indonesia Market Share Analysis (%) by End User, 2021 & 2032

Figure 125: Malaysia Market Value Proportion Analysis, 2021

Figure 126: Global Vs. Malaysia Growth Comparison, 2021 - 2032

Figure 127: Malaysia Market Share Analysis (%) by Product, 2021 & 2032

Figure 128: Malaysia Market Share Analysis (%) by End User, 2021 & 2032

Figure 129: Thailand Market Value Proportion Analysis, 2021

Figure 130: Global Vs. Thailand Growth Comparison, 2021 - 2032

Figure 131: Thailand Market Share Analysis (%) by Product, 2021 & 2032

Figure 132: Thailand Market Share Analysis (%) by End User, 2021 & 2032

Figure 133: Oceania Market Value (US$ Mn) Analysis, 2012-2021

Figure 134: Oceania Market Value (US$ Mn) Forecast, 2022-2032

Figure 135: Oceania Market Value Share, by Product (2022 E)

Figure 136: Oceania Market Value Share, by End User (2022 E)

Figure 137: Oceania Market Value Share, by Country (2022 E)

Figure 138: Oceania Market Attractiveness Analysis by Product, 2022–2032

Figure 139: Oceania Market Attractiveness Analysis by End User, 2022–2032

Figure 140: Oceania Market Attractiveness Analysis by Country, 2022–2032

Figure 141: Australia Market Value Proportion Analysis, 2021

Figure 142: Global Vs. Australia Growth Comparison, 2021 - 2032

Figure 143: Australia Market Share Analysis (%) by Product, 2021 & 2032

Figure 144: Australia Market Share Analysis (%) by End User, 2021 & 2032

Figure 145: New Zealand Market Value Proportion Analysis, 2021

Figure 146: Global Vs New Zealand Growth Comparison, 2021 - 2032

Figure 147: New Zealand Market Share Analysis (%) by Product, 2021 & 2032

Figure 148: New Zealand Market Share Analysis (%) by End User, 2021 & 2032

Figure 149: Middle East & Africa Market Value (US$ Mn) Analysis, 2012-2021

Figure 150: Middle East & Africa Market Value (US$ Mn) Forecast, 2022-2032

Figure 151: Middle East & Africa Market Value Share, by Product (2022 E)

Figure 152: Middle East & Africa Market Value Share, by End User (2022 E)

Figure 153: Middle East & Africa Market Value Share, by Country (2022 E)

Figure 154: Middle East & Africa Market Attractiveness Analysis by Product, 2022–2032

Figure 155: Middle East & Africa Market Attractiveness Analysis by End User, 2022–2032

Figure 156: Middle East & Africa Market Attractiveness Analysis by Country, 2022–2032

Figure 157: GCC Countries Market Value Proportion Analysis, 2021

Figure 158: Global Vs GCC Countries Growth Comparison, 2021 - 2032

Figure 159: GCC Countries Market Share Analysis (%) by Product, 2021 & 2032

Figure 160: GCC Countries Market Share Analysis (%) by End User, 2021 & 2032

Figure 161: Turkey Market Value Proportion Analysis, 2021

Figure 162: Global Vs. Turkey Growth Comparison, 2021 - 2032

Figure 163: Turkey Market Share Analysis (%) by Product, 2021 & 2032

Figure 164: Turkey Market Share Analysis (%) by End User, 2021 & 2032

Figure 165: South Africa Market Value Proportion Analysis, 2021

Figure 166: Global Vs. South Africa Growth Comparison, 2021 - 2032

Figure 167: South Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 168: South Africa Market Share Analysis (%) by End User, 2021 & 2032

Figure 169: North Africa Market Value Proportion Analysis, 2021

Figure 170: Global Vs North Africa Growth Comparison, 2021 - 2032

Figure 171: North Africa Market Share Analysis (%) by Product, 2021 & 2032

Figure 172: North Africa Market Share Analysis (%) by End User, 2021 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Clinical Chemistry Analyzers Market

Published : February 2019

Healthcare

Blood Coagulation Analyzers Market

Published : July 2017

Healthcare

Chronic Lymphocytic Leukemia Market

Published : December 2016

Google translate

Coagulation Analysers Market